Veradigm PE Ratio 2012-2022 | MDRX
Current and historical p/e ratio for Veradigm (MDRX) from 2012 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veradigm PE ratio as of September 18, 2026 is 0.00.
| Veradigm PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-18 | 4.70 | 0.00 | |
| 2022-12-31 | 17.64 | $-0.77 | 0.00 |
| 2022-09-30 | 15.23 | $0.43 | 35.42 |
| 2022-06-30 | 14.83 | $0.43 | 34.49 |
| 2022-03-31 | 22.52 | $1.12 | 20.11 |
| 2021-12-31 | 18.45 | $1.01 | 18.27 |
| 2021-09-30 | 13.37 | $4.88 | 2.74 |
| 2021-06-30 | 18.51 | $4.76 | 3.89 |
| 2021-03-31 | 15.02 | $4.56 | 3.29 |
| 2020-12-31 | 14.44 | $4.37 | 3.30 |
| 2020-09-30 | 8.14 | $-0.31 | 0.00 |
| 2020-06-30 | 6.77 | $-0.34 | 0.00 |
| 2020-03-31 | 7.04 | $-1.19 | 0.00 |
| 2019-12-31 | 9.82 | $-1.10 | 0.00 |
| 2019-09-30 | 10.98 | $1.16 | 9.47 |
| 2019-06-30 | 11.63 | $0.99 | 11.75 |
| 2019-03-31 | 9.54 | $2.25 | 4.24 |
| 2018-12-31 | 9.64 | $2.07 | 4.66 |
| 2018-09-30 | 14.25 | $-0.03 | 0.00 |
| 2018-06-30 | 12.00 | $0.01 | 1200.00 |
| 2018-03-31 | 12.35 | $-1.20 | 0.00 |
| 2017-12-31 | 14.55 | $-1.09 | 0.00 |
| 2017-09-30 | 14.23 | $-1.16 | 0.00 |
| 2017-06-30 | 12.76 | $-1.06 | 0.00 |
| 2017-03-31 | 12.68 | $-0.26 | 0.00 |
| 2016-12-31 | 10.21 | $-0.14 | 0.00 |
| 2016-09-30 | 13.17 | $-0.01 | 0.00 |
| 2016-06-30 | 12.70 | $0.02 | 635.00 |
| 2016-03-31 | 13.21 | $0.06 | 220.17 |
| 2015-12-31 | 15.38 | $-0.01 | 0.00 |
| 2015-09-30 | 12.40 | $-0.11 | 0.00 |
| 2015-06-30 | 13.68 | $-0.23 | 0.00 |
| 2015-03-31 | 11.96 | $-0.31 | 0.00 |
| 2014-12-31 | 12.77 | $-0.37 | 0.00 |
| 2014-09-30 | 13.42 | $-0.48 | 0.00 |
| 2014-06-30 | 16.05 | $-0.60 | 0.00 |
| 2014-03-31 | 18.03 | $-0.64 | 0.00 |
| 2013-12-31 | 15.46 | $-0.59 | 0.00 |
| 2013-09-30 | 14.87 | $-0.60 | 0.00 |
| 2013-06-30 | 12.94 | $-0.28 | 0.00 |
| 2013-03-31 | 13.59 | $-0.11 | 0.00 |
| 2012-12-31 | 9.42 | $-0.01 | 0.00 |
| 2012-09-30 | 12.42 | $0.26 | 47.77 |
| 2012-06-30 | 10.93 | $0.31 | 35.26 |
| 2012-03-31 | 16.60 | $0.35 | 47.43 |
| 2011-12-31 | 18.94 | $0.39 | 48.56 |
| 2011-09-30 | 18.02 | $0.22 | 81.91 |
| 2011-06-30 | 19.42 | $0.13 | 149.38 |
| 2011-03-31 | 20.99 | $0.14 | 149.93 |
| 2010-12-31 | 19.27 | $0.07 | 275.29 |
| 2010-09-30 | 18.47 | $0.22 | 83.95 |
| 2010-06-30 | 16.10 | $0.33 | 48.79 |
| 2010-05-31 | 18.81 | $0.24 | 78.38 |
| 2010-03-31 | 19.58 | $0.34 | 57.59 |
| 2010-02-28 | 17.89 | $0.31 | 57.71 |
| 2009-12-31 | 20.23 | $0.28 | 72.25 |
| 2009-11-30 | 19.20 | $0.28 | 68.57 |
| 2009-09-30 | 20.27 | $0.27 | 75.07 |
| 2009-08-31 | 14.85 | $0.13 | 114.23 |
| 2009-05-31 | 12.91 | $0.11 | 117.36 |
| 2009-02-28 | 8.70 | $0.17 | 51.18 |
| 2008-11-30 | 7.70 | $0.12 | 64.17 |
| 2008-09-30 | 6.61 | $0.17 | 38.88 |
| 2008-08-31 | 7.62 | $0.10 | 76.20 |
| 2008-06-30 | 6.59 | $0.16 | 41.21 |
| 2008-05-31 | 6.60 | $0.22 | 30.02 |
| 2008-03-31 | 5.48 | $0.29 | 18.91 |
| 2008-02-29 | 5.67 | $0.36 | 15.75 |
| 2007-12-31 | 10.32 | $0.34 | 30.35 |
| 2007-11-30 | 9.40 | $0.04 | 235.00 |
| 2007-09-30 | 14.36 | $0.05 | 287.25 |
| 2007-06-30 | 13.54 | $0.06 | 225.65 |
| 2007-05-31 | 13.05 | $0.02 | 652.51 |
| 2007-03-31 | 14.25 | $0.27 | 52.76 |
| 2006-12-31 | 14.34 | $0.22 | 65.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.587B | $0.594B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |